Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
24 Sep 2015
21 CFR 56.108(a)(1)
Initial and continuing reviews
Cited by Anthony N Onianwa, Anthony W Thomas
24 Sep 2015
21 CFR 56.110(c)
Method to keep members advised
Cited by Anthony N Onianwa, Anthony W Thomas
24 Sep 2015
21 CFR 56.115(a)(3)
Records of continuing review
Cited by Anthony N Onianwa, Anthony W Thomas
24 Sep 2015
21 CFR 56.115(a)(4)
Copies of IRB/CI correspondence
Cited by Anthony N Onianwa, Anthony W Thomas
Inspected site
AIAllendale IRBOld Lyme, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 56.108(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.110(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(4) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 4 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere